![冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第1頁(yè)](http://file4.renrendoc.com/view4/M01/03/0A/wKhkGGZC0ACAZON7AAFClvljnOo146.jpg)
![冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第2頁(yè)](http://file4.renrendoc.com/view4/M01/03/0A/wKhkGGZC0ACAZON7AAFClvljnOo1462.jpg)
![冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第3頁(yè)](http://file4.renrendoc.com/view4/M01/03/0A/wKhkGGZC0ACAZON7AAFClvljnOo1463.jpg)
![冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第4頁(yè)](http://file4.renrendoc.com/view4/M01/03/0A/wKhkGGZC0ACAZON7AAFClvljnOo1464.jpg)
![冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第5頁(yè)](http://file4.renrendoc.com/view4/M01/03/0A/wKhkGGZC0ACAZON7AAFClvljnOo1465.jpg)
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
CoronaryAtheroscleroticHeartDiseasesAffiliatedHospitalofJiningMedicalCollegeDept.ofCardiacCareUnitGuoxiaDongdong.0321@163.com25/14/2024ContentsAtherosclerosisStableAnginaPectorisAcuteCoronarySyndromeUAandNSTEMIAMI(STEMI)35/14/2024Self-study
VariantAnginaCardiacSyndromeXSilentMyocardialIschemiaMyocardialBridging45/14/2024WhatIsAtherosclerosis?Atherosclerosisisthedescriptivetermforthickenedandhardenedlesionsofthemediumandlargemuscularandelasticarteries.55/14/2024WhatIsCoronaryHeartDisease?65/14/2024CoronaryheartdiseaseatherosclerosisCoronarystenosiscoronaryspasmMyocardialischemia,necrosisIschemicheartdisease75/14/202485/14/2024Atherosclerosis95/14/2024FoamcellFattysteak
atheromatousplaquerupturedplaquesFibrousplaqueEndothelialdamagefirstdecadeThirddecadeForthdecadeAdaptedfromStaryHCetal.Circulation1995;92:1355-1374.mediumdamage5/14/202410Whatdamagedoesatherosclerosiscause?
115/14/2024CommonlocationCoronaryHeartDiseaseCarotidArteryDiseasePeripheralArterialDiseaseChronicKidneyDisease125/14/2024Howdoesatherosclerosisstartandprogress?135/14/2024ElevatedlevelsofcholesterolandtriglyceridesinthebloodHighbloodpressureCigarettesmoking145/14/2024BiologicalprocessesAccumulationofintimalcellssmoothmusclecellsMacrophagesT-lymphocytes155/14/2024BiologicalprocessesProliferatedconnectivetissuematrixcollagenelastic
fibersproteoglycans
165/14/2024Biologicalprocesses3.Accumulationoflipid175/14/2024Atherosclerosis-Hypothesis
HypothesisoflipoproteininfiltrationAggregationofplateletsandthrombosisClonaltheoryTheresponse-to-injuryhypothesis185/14/2024Highbloodpressure,bacterium,virus,toxin,ox-LDL,immunefactor,vasoactivesubstance.Plateletsareactivated,
adhesionandaggregationofplatelets.Lipidoses,growthfactor,proliferationofsmoothmuclecells,collagen,lipolyticenzyme.Response-to-injury
195/14/2024Pathologyandpathophysiology
FattysteakFibrousplaqueComplicatedlesion205/14/2024InitiationofAtherosclerosis
Fattysteakformation215/14/2024InitiationofAtherosclerosis225/14/2024fibrousplaque235/14/2024245/14/2024
255/14/2024ThinCapVulnerablePlaqueThrombusUnstable“ActiveVolcano”ThickCapCalcifiedPlaqueFlow-limitingLesionStableAngina“DormantVolcano”SAPACSpressureorasqueezingpain!!!265/14/2024UnstableandStablePlaques薄的纖維帽炎性細(xì)胞少的平滑肌細(xì)胞內(nèi)皮細(xì)胞不完整巨噬細(xì)胞較厚的纖維帽沒(méi)有炎性細(xì)胞泡沫細(xì)胞完整的內(nèi)皮細(xì)胞較多平滑肌細(xì)胞LibbyP.Circulation.1995;91:2844-2850.unstablestable5/14/202428Atherosclerosis
ClinicalstagesAbsenceofsymptomorstageofincubationischemianecrosis(target
organ)fibrosis295/14/2024clinicalmanifestation
GeneralmanifestationAorticatherosclerosisCoronaryarteryatherosclerosisCerebral
atherosclerosisRAatherosclerosisMesentericatherosclerosisPeripheral
arteryatherosclerosis305/14/2024Laboratory
ExaminationLackofsensitiveandspecificmethodsforearlydiagnosisDyslipidemiaX-ray:DSAshowseverityofstenosisDopplerultrasound:bloodflow315/14/2024Laboratory
Examinationradionuclide:detectionofischemiaEchocardiogram:CHDECGandstresstest:CHDAngiography:themostdirectwayIntravascularultrasound,angioscopeCT,MRI325/14/2024Riskfactors
1.Lipiddisorders(Dyslipidemia)Increasedcholesterol:TcandLDL-c,TG,ApoB,Lp(a)Decreasedcholesterol:HDL-capoA2.Hypertension335/14/2024Riskfactors3.DM,MetabolicsyndromeorinsulinresistancesyndromeMorediffuselesionCADequivalent75-80%causeofdeathinadultDMarevasculardiseases:CAD,cerebrovasculardisease,orperipheralvasculardisease345/14/20247yearsincidenceofdeath/non-fatalMI(EastWestStudy)*ThesepatientshadnohistoryofmyocardialinfarctionHaffnerSM,etal.NEnglJMed.1998;339:229–234.05101520253035404550EventsofMIin7yearsNohistoryofMIOMINohistoryofMI*OMInon-diabetics diabetics n=1373 n=1059P<0.001P<0.0014%19%20%45%DM:CADequivalent355/14/2024Riskfactors
4.
Cigarettesmoking:morethrombogenic5.
Familyhistory6.
Aging:>40yrsadults,4/5fatalmyocardialinfarctionoccuredinpatiens>65yrs7.Malegender/postmenopausalstate:male:female=2:1,mendevelopCHD10-15yrsearlierthanwomen8.alcohol9.Others:diet,homocysteine,hemostaticfactorsinflammation/infection365/14/2024
Drugtherapy
anti-platelet:
aspirin,clopidogrel,GPIIb/IIIainhitibor,Dipyridamole,cilostazolLipid-loweringHMG-CoAreductaseinhibitors(statins)375/14/2024DoubtsofpatientsQuest1:Mybloodpressureisonlyabout100/60mmHg,Whygivemehypotensorlotensin?385/14/2024DoubtsofpatientsQuestion2:Myshapeisnotfat,lipidisnothigh,whygivemelipid-loweringdrugs,madeamistake?395/14/2024DoubtsofpatientsQuestion3:Ihavecoronaryheartdisease,thenshouldIdolessactivities
inordertoprotecttheheart?405/14/2024
CoronaryHeartDisease(CHD)
5/14/202441ClinicalTypeSilentmyocardialischemiaAnginapectorisMyocardialinfarctionIschemiccardiomyopathySuddencardiacdeath5/14/202442SilentMyocardialIschemiaDefinedasdocumentedepisodesofischemianotassociatedwithanytypicaloratypicalsymptomsthatamongpatientswithobstructivecoronaryarterydisease.TypeI:myocardialischemiaisdetectedonroutineECG,24hambulatoryECGmonitoring(Holter),etc.butnotexperienceanginaatanytime;TypeII:patientsaremostfrequentlyencounteredinclinicalpractice.Someepisodesofischemiaareassociatedwithchestdiscomfortandotherepisodesareasymptomatic.5/14/202443IschemicCardiomyopathySymptomsofheartfailure,causedbyischemicmyocardialdysfunction,diffusefibrosis,andmultipleinfarction,aloneorincombination.Manifestations:ventriclesenlargement(dominantleftventricle),heartfailureandarrhythmias.5/14/202444SuddenCardiacDeathSCDisnaturaldeathduetocardiaccauses,heraldedbyabruptlossofconsciousnesswithin1houroftheonsetofacutesymptoms.Thetimeandmodeofdeathareunexpected.WHOdefinition:unexpecteddeathwithin6hours.Thisdefinitionincorporatesthekeyelementsofnatural,
rapidandunexpected.OnehalfofSCDduetocoronaryheartdisease,causedbyseverearrhythmias,suchasventricularfibrillationandcardiacarrest.5/14/202445AcuteCoronarySyndromeACSrepresentsaspectrumofconditions.Acuteplaquechangecharacterizedbyplaqueruptureandexposureofsubstancesthatpromoteplateletactivationandthrombingeneration.5/14/202446STABLEANGINAPECTORIS475/14/2024Definition
Acuteandtransientmyocardialischemiaandanoxaemia.Usuallycausedbycoronaryinsufficiencyduringexertion.485/14/2024Characteristicsparoxysmalprecordialsqueezing-likechestpain,behindthemidsternumradiatedtoleftshoulderandupperarmprecipitatedbystressorexertionrelievedrapidlybyrestornitrates495/14/2024
hypoxiaCoronarystenosis(others:aorticvalvedisease,HOCM)+Myocardialoxygendemand(HRXSBP)increased
myocardialhypoxiaacumulationofmetabolicproduct,stimulateC1-5tocausethesensationofchestpain
mechanism505/14/2024inangiographySignificantcoronarylesionwithdiameterstenosis>70%in75%ptsNosignificantstenosisinabout5-10%pts,Ischemiamayberelatedtocoronaryspasmormicrovasculardysfunction.PathologyStableanginapectoris515/14/2024pathophysiology1.MetabolicandelectrophysiologyATPreduced,accumulationofacidsubstancesDysfunctionofionpump(Na+-K+,andNa+-Ca++)Earlydepolarization(STdeviation)2.LVfunctionandhemodynamicsituationLVcontractility,systolicBP,strokevolume,cardiacoutputdecreasedLVEDpressureandvolumeStunningofmyocardiumStableanginapectoris525/14/2024symptom:chestpainlocation
behindorslightlytotheleftofthemidsternumnodefiniteborderlineradiatedtotheleftshoulderandupperarmAtypicallocation:lowerjaw,thebackofneckClinicalmanifestationStableanginapectoris535/14/2024character:tightness,squeezing,burning,pressing,choking,bursting,rarelysharpduration:3-5minsprecipitatingfactor
exertionoremotionalagitationpainrelief:withinseveralminsafterrestorusingnitroglycerinClinicalmanifestationStableanginapectoris555/14/2024PhysicalexaminationincreasedHR,elevatedBPanxietycoolandsweatyskinoccasionally
galloprhythm,transientsystolicmurmurClinicalmanifestationStableanginapectoris565/14/2024
Auxiliaryexamination1.ECG:Resting
ECGECGduringchestpain:ST-Tchangefoundin95%ptsHolter:detectofslientischemiaStresstesting:Criteriaforpositive:STsegmentdepression
0.1mV,last2minscontraindication:AMI,UAP,myocarditis,Hypertension,heartfailure,aorticstenosis,HOCM,severarrhythmia,aorticaneurysmEndofthetest:STor≥0.2mV,APattacks,BP>220mmHg,BPdrop,ventriculararrhythmiaStableanginapectoris575/14/2024StresstestrestExersciseStableanginapectoris585/14/2024
2.Echocardiography:3.Scintigraphyassessment:CandetectfillingdefectofInfarctionarea4.X-rayofheart 5.coronaryangiography:finaldiagnose6.others:IVUSAuxiliaryexaminationStableanginapectoris595/14/2024CoronaryAngiography605/14/2024StableAnginaPectorisDiagnosisChestpainriskfactorsECGevidenceofischemiaduringchestpainangiography615/14/2024Cardiovascular
causesNoncardiaccausesStableAnginaPectorisDifferentialdiagnosis625/14/2024Cardiovascular
cause
MyocardialinfarctionPericarditisAorticdissectionPulmonaryembolismPulmonaryhypertension635/14/2024Noncardiac
cause
PneumoniawithpleurisySpontaneouspneumothoraxMusculoskeletaldisordersHerpeszosterEsophagealrefluxPepticulcer645/14/2024Generaltreatment:riskfactorscontrol2.Drugtherapy3.Coronaryrevascularization:percutaneouscoronaryintervention(PCI)Coronaryarterybypasssurgery(CABG)SVG,IMAGTreatmentStableAnginaPectoris655/14/2024BloodandoxygensupplytotheheartMyocardial
bloodflowMyocardialoxygen
consumption4%oftotal
cardiacoutput
suppliedtothe
myocardium12%oftotalbodyoxygen,
usedatrestby
myocardium5/14/202466CoronaryReserveMyocardial
bloodflow
increasesupto
4times...…tomeet
increased
myocardialoxygen
demand5/14/202467Myocardialoxygen
supplyanddemandO2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2supplyO2demand5/14/202468AimsofmedicaltherapyArterialvasodilatationReducesarterial
resistanceReducesafterloadDecreases
sympatheticdriveReduceheartrate
andcontractileforceReducescardiacworkLVRVDilatationof
coronaryarteriesImprovescoronary
supplyVenodilatationReduces
venousreturnReducespreload5/14/202469antianginalandanti-ischemictherapyDrugtherapyOxygensupplyOxygendemanda.Nitratesb.Betablockersc.Calciumantagonistsd.DrugsimprovingmetabolismStableAnginaPectoris705/14/2024Drugtherapya.Nitratesloweroxygendemand:decreasearteriolarandvenoustone,reducepreloadandafterloadincreasecoronarysupply:CoronarydilatationNitroglycerinIsosorbidedinitrateisosorbide5-mononitrate(long-actingnitrates)StableAnginaPectoris715/14/2024NitratesinanginaReducepreload
through
venodilatationReduceafterloadby
loweringarterialresistanceReduceplateletaggregationIncreasecoronaryperfusion,includingischaemicareasReversalofcoronaryspasm5/14/202472b.?-blockers:reducemyocardialoxygen:reduceHR,myocardialcontractility,BP,theLVwallstressAbslutecontraindications:severbradycardia:high-degreeA-Vblock,SSS,severeunstableLVfailureRelativecontraindications:asthmaandbronchospasticdiseaseperipheralvasculardisease?1-selective:metoprolol,atenolol,bisoprololDrugtherapyStableAnginaPectoris735/14/2024c.Calciumantagonists:Increaseoxygensupply:dilateconduitandresistancevessels,releasespasm,improvemicrovascularfunctionDecreaseoxygendemand:negativeinotropiceffect,decreaseBPAntiplateleteffectd.DrugsimprovingmetabolismDrugtherapyStableAnginaPectoris745/14/2024preventMIanddeaththerapya.antiplateletangents:ASAclopidogrelCilostazolb.Lipid-loweringangents:statinsc.Angiotesin-convertingenzymeinhibitor(ACEI)DrugtherapyStableAnginaPectoris755/14/2024stentingStableAnginaPectoris765/14/2024UnstableAngina(UA)andnon-STEMI775/14/2024ACSNon-STelevationSTelevationUnstableanginaNon-QwaveAMIQwaveAMI*positiveserumcardiacmarkers****##occasionallyvariantanginaAcuteCoronarySyndrome(ACS)785/14/2024PathophysiologyofACS
stableangina UAP&non-Q-wAMI Q-wAMIAngiographicthrombus
0-1% 75% >90%IncreasedFPA/TAT 0-5% 60-80% 80-90%Activatedplatelets 0-5% 70-80% 80-90%Acutecoronaryocclusion 0-1% 10-25% >90%mortality 1-2% 3-8% 6-15%FPA:fibrinopeptideATAT:thrombin-antithrombincomplexesUAandnon-STEMI795/14/2024Occuringatrest(orwithmininalexertion):last>20minsseverandofnew-onset:within1-2months,CCSIIIOccuringwithacrescendopattern:DeteriorationofCCSclassfication,atleastCCSIIIDefinition
UAandnon-STEMIAnginapectorisorequivalentischemicdiscomfortwithatleastoneofthethreefeatures805/14/2024BraunwaldclassificationofunstableanginaSeverity:ClassI:New-onset,oracceleratedsevereanginanorestpainwithin2monthsClassII:Anginaatrest,subacuteanginaatrest(withintheprecedingmonthbutnotwithin48h)ClassIII:Anginaatrest,acute(withinthepreceding48h)UAandnon-STEMI815/14/2024BraunwaldclassificationofunstableanginaClinicalCircumstancesClassA:SecondaryUAPaclearlyidentifiedconditionextrinsictothecoronaryvascularbedthathasintensifiedmyocardialischemia,e.g.anemia,hypotension,tachy-arrhythmiaClassB:PrimaryunstableanginaClassC:Post-infarctionUAP(within2weeksofadocumentedMI)UAandnon-STEMI825/14/2024mechanism:
1.plaqueruptureanderosion,withnonocclusivethrombus2.dynamicobstruction:Vasoconstruction3.progressivemechnialobstruction(rapidlyadvancingorISRfollowingstenting)4.secondaryUAInflammationThrombogenesisUAandnon-STEMI835/14/2024
ECG:Non-STEMI:STdepressionlast>12hrCardiacbiomarkersofmyocardiumdamage:cTnT,cTnICK-MBUAPandnon-STEMICoronaryangiographyAngioscopyandIVUSOtherlaboratorytests845/14/2024Treatment1.Genearlmanagement:rest,oxygen,CCU2.DrugtherapyA.Anti-ischemicdrug:intravenously,orallynitrates
-blockerCalcium
antagnoist:firstchoiceforvariantanginaMorphinesulfateUAandnon-STEMI855/14/2024Treatment
2.Drugtherapy:B.antithrombotictherapya.Anti-plateletAspirin:early,300mgloadingdoseADP-receptorantagonist:clopidogrel300mg-600mgloadingdose,75mg/dGPIIb/IIIareceptorinhibitor:usedinptsplannedtoPCIb.Anticoagulationtherapy:HeparinLowmolecularweightheparin(LMWH)Directanti-thrombindrug:bivalirudin,hirudin
UAandnon-STEMI865/14/2024Treatment2.Drugtherapy:C.othermedicaltherapy
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 湘教版數(shù)學(xué)七年級(jí)上冊(cè)1.5.2《有理數(shù)的除法》聽(tīng)評(píng)課記錄
- 常州信息職業(yè)技術(shù)學(xué)院《城市規(guī)劃原理》2023-2024學(xué)年第二學(xué)期期末試卷
- 商丘工學(xué)院《區(qū)域地質(zhì)與礦產(chǎn)調(diào)查》2023-2024學(xué)年第二學(xué)期期末試卷
- 成都醫(yī)學(xué)院《醫(yī)學(xué)創(chuàng)新》2023-2024學(xué)年第二學(xué)期期末試卷
- 廣西工業(yè)職業(yè)技術(shù)學(xué)院《護(hù)理教育學(xué)》2023-2024學(xué)年第二學(xué)期期末試卷
- 榆林學(xué)院《中外語(yǔ)言文化比較》2023-2024學(xué)年第二學(xué)期期末試卷
- 西安明德理工學(xué)院《細(xì)胞生物學(xué)專題》2023-2024學(xué)年第二學(xué)期期末試卷
- 魚塘土方回填施工方案
- 物業(yè)小區(qū)外墻保溫施工方案
- 砼網(wǎng)格護(hù)坡施工方案
- 2024黑龍江公務(wù)員考試【A類、B類、省直、筆試】四套真題及答案
- 2025年中國(guó)高價(jià)HPV疫苗行業(yè)競(jìng)爭(zhēng)格局分析及投資規(guī)劃研究報(bào)告
- 2025年春新北師大版物理八年級(jí)下冊(cè)課件 第七章 運(yùn)動(dòng)和力 第四節(jié) 同一直線上二力的合成
- 2025年公司年會(huì)活動(dòng)總結(jié)樣本(3篇)
- 22G614-1 砌體填充墻結(jié)構(gòu)構(gòu)造
- DL-T5153-2014火力發(fā)電廠廠用電設(shè)計(jì)技術(shù)規(guī)程
- 眼科疾病與視覺(jué)健康
- 運(yùn)營(yíng)維管段安全保護(hù)區(qū)環(huán)境管理實(shí)施細(xì)則(試行)
- 《C++程序設(shè)計(jì)》完整教案
- 美國(guó)LM2500艦用燃?xì)廨啓C(jī)
- RNA-seq研究方法與策略-zzz
評(píng)論
0/150
提交評(píng)論